|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Gross premiums written (Note 7) | |||||
| Net premiums written (Note 7) | |||||
| Decrease (increase) in unearned premiums | |||||
| Net premiums earned (Note 7) | |||||
| Net investment income (Note 5) | |||||
| Net foreign exchange gains (losses) | |||||
| Equity in earnings (losses) of other ventures (Note 5) | |||||
| Other income (loss) | |||||
| Net realized and unrealized gains (losses) on investments | |||||
| Total revenues | |||||
| Expenses | |||||
| Net claims and claim expenses incurred (Notes 7 and 8) | |||||
| Acquisition expenses | |||||
| Operational expenses | |||||
| Corporate expenses | |||||
| Interest expense (Note 9) | |||||
| Total expenses | |||||
| Income (loss) before taxes | |||||
| Income tax benefit (expense) (Note 15) | |||||
| Net income (loss) | |||||
| Net (income) loss attributable to redeemable noncontrolling interests (Note 10) | |||||
| Net income (loss) attributable to RenaissanceRe | |||||
| Dividends on preference shares (Note 12) | |||||
| Net income (loss) available (attributable) to RenaissanceRe common shareholders | |||||
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – basic (in dollars per share) | |||||
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – diluted (in dollars per share) |
Loading...